[function_title]

  • Display Type:
  • Text List
  • Abstract List
  • 1  Construction and exploration of medical quality control system for children’s growth and development related diseases
    Huang Ke,Fu Junfen
    2022, 47(3):253-255.
    [Abstract](243) [HTML](0) [PDF 487.78 K](268)
    Abstract:
    Children’s health is an important cornerstone of national health. It’s imminent to establish the standardized diagnosis and treatment of children’s growth and development related diseases and to improve the medical quality control system. Taking the “Zhejiang Model” as a pattern,establishing and promoting the nationwide medical quality control of children’s growth and development related diseases will play an important role in improving the skills of specialists,supplementing the specialist training system and boosting the medical quality. There is an urgent need to design and expand the medical quality control of these diseases nationwide. With the help of artificial intelligence technology,the organizational structure and working mechanism is to be improved. We suggest to carry out multi-form,multi-level and competency oriented phased advanced training and evaluation,and build a national medical quality control management system and platform for the children’s growth and development related diseases.
    2  Lifetime management of small for gestational age
    Wu Wei,Luo Xiaoping
    2022, 47(3):256-258.
    [Abstract](140) [HTML](0) [PDF 399.85 K](209)
    Abstract:
    Small for gestational age(SGA) is a group of heterogeneous diseases,and technical advances in gene detection provide the opportunity for its precision diagnosis. With deepening understanding of SGA,clinicians recognize a poor fetal growth as well as post-natal adverse growth modes have adverse effects on the short-term and long-term health outcomes. Therefore,we outline the manage-ment priorities and strategies in different periods of SGA to provide basics for the realization of lifelong management.
    3  Interpretation of Consensus Statement on the Diagnosis and Endocrine Treatment of Children with Disorder of Sex Development
    Lü Yongfen,Li Pin
    2022, 47(3):259-262.
    [Abstract](383) [HTML](0) [PDF 1.44 M](244)
    Abstract:
    Disorder of sex development(DSD) is a group of chromosomal karyotypes,gonadal phenotypes,and gonadal anatomical discordant disorders. In order to further deepen the understanding of DSD by clinicians,standardize the diagnosis and treatment of patients with DSD,the Subspecialty Group of Endocrinologic,Hereditary and Metabolic Diseases,the Society of Pediatrics,the Chinese Medical Association issued Consensus Statement on the Diagnosis and Endocrine Treatment of Children with Disorder of Sex Development. The consensus provides clinicians with information on DSD classification,clinical evaluation,gender identification,endocrine hormone therapy and associated tumor risk. This paper interprets and further discusses the main contents of the consensus.
    4  Study on rapidly progressive central precocious puberty association with serum anti-Müllerian hormone and inhibin B levels in girls
    Yang Yu,Zhou Zudan,Yang Li,Xie Liling,Zou Haiying,Zhang Dongguang,Huang Hui,Shuai Xia,Yu Zhen,Xiong Xiangyu,Shi Qiao,Xu Lei
    2022, 47(3):263-267.
    [Abstract](160) [HTML](0) [PDF 585.08 K](254)
    Abstract:
    Objective:To study the correlation and clinical significance of the serum anti-Müllerian hormone(AMH) and inhibin B(INHB) levels of girls with the progression of central precocious puberty(CPP),and point out new directions for the diagnosis and treatment of rapidly progressive CPP(RP-CPP) girls. Methods:A total of 55 girls with CPP who were diagnosed in Department of Endocrinology,Genetics and Metabolism of Jiangxi Provincial Children’s Hospital were included in our research. Then,32 of them were divided into RP-CPP group(n=32) and 23 of them into SP-CPP group(n=23) according to the progressive index. Meanwhile,30 immature and age-matched girls were collected as the normal control group. Results:The serum levels of AMH in RP-CPP,SP-CPP and control groups were significantly different(P<0.05). Significant differences were founded between RP-CPP group and control group and also between SP-CPP and control group(P<0.05),while no statistical differences were found between RP-CPP group and SP-CPP group(P >0.05). AMH levels of girls were significantly negatively correlated with basal-LH,basal-FSH,peak-LH,and peak-FSH in the RP-CPP group. Conclusion:Our results suggest that AMH and INHB are associated with the progress of RP-CPP girls,meanwhile they are potential laboratory indicators to identify RP-CPP girls rapidly in clinical work.
    5  Clinical and genetic analysis of androgen insensitivity syndrome
    Wu Ting,Zhu Min
    2022, 47(3):268-272.
    [Abstract](179) [HTML](0) [PDF 675.75 K](173)
    Abstract:
    Objective:To analyze the clinical and genetic characteristics of androgen insensitivity syndrome(AIS). Methods:Clinical data of 10 AIS patients who were treated in the Children's Hospital of Chongqing Medical University from 2015 to 2020 were collected in the study. The DNA was extracted from the peripheral blood of the children and their parents. The endocrine disease-related genes were sequenced,and family DNA samples were verified by Sanger sequencing. Results:Androgen receptor(AR) gene mutations were identified in all patients,of which five mutations had not been described previously,namely c.401dupA(p.P135Afs23),1 350 bp deletion mutation,c.2505C>G(p.Y835X),c.1747T>C(p.F583L) and c.610G>T(p.E204X). Among them,c.610G>T(p.E204X) was a chimera mutation. Conclusion:All five undescribed mutations in this study may be pathogenic,suggesting that gene testing is helpful to the diagnosis of AIS,and is beneficial to clinical decision-making and genetic counseling of AIS patients.
    6  Study on serum markers of bone formation with idiopathic central precocious puberty in girls
    Dong Guoqing,Li Mingzhu,Huang Miao,Lu Xiyan,Liu Peipei,Li Jianxu,Zhong Lihua
    2022, 47(3):273-277.
    [Abstract](530) [HTML](0) [PDF 722.95 K](229)
    Abstract:
    Objective:To observe the changes of serum bone formation markers such as amino-terminal pro-C-type natriuretic peptide(NT-proCNP),bone alkaline phosphatase(BAP),osteocalcin(OC) and insulin-like growth factor-1(IGF-1) in girls with idiopathic central precocious puberty(ICPP),so as to explore the relationship among them. Methods:A total of 100 ICPP girls and 100 healthy controls were collected in the study. The serum bone formation indicators(NT-proCNP,OC,BAP and IGF-1) were measured by ELISA. SPSS 26.0 was used for relevant statistical analysis. Results:①The levels of NT-proCNP,OC,BAP and IGF-1 in the ICPP group were higher than those of the normal control group(all P<0.05),and serum NT-proCNP and IGF-1 levels in Tanner Ⅱ were higher than those in the stage Ⅲ(P<0.05). ② The difference between bone age and chronological age in girls with ICPP was negatively correlated with NT-proCNP and positively correlated with IGF-1. ③Characteristics of ROC curve showed that serum NT-proCNP,OC,BAP and IGF-1 had certain diagnostic value for ICPP,and IGF-1 had the highest sensitivity and specificity. ④After six months of treatment with GnRHa,the levels of NT-proCNP,OC,BAP and IGF-1 in ICPP were all lower than those before treatment(all P<0.05). Compared with the normal control group,the concentrations of NT-proCNP,OC and IGF-1 in blood were not statistically different,while the concentration of BAP in blood was still higher in ICPP after six months of treatment with GnRHa. Conclusion:Serum levels of NT-proCNP,OC,BAP and IGF-1 can indirectly reflect the growth and development of girls with ICPP,so it is partly valuable for early diagnosis of ICPP. We suggest that these indexes may be used to observe the therapeutic effect of ICPP.
    7  A case report of familial male-limited precocious puberty induced by missense mutation of LHCGR gene
    Zhao Tong,Yang Sen,Zhang Yili,Shi Hongjiao,Cui Lanwei
    2022, 47(3):278-281.
    [Abstract](117) [HTML](0) [PDF 1.00 M](199)
    Abstract:
    8  Clinical features and literature review of early youth and rapid development of 47,XXY Klinefelter’s syndrome
    Xie Liling,Zhang Yuqin,Yang Yu,Yang Li,Zhang Dongguang,Huang Hui
    2022, 47(3):282-284.
    [Abstract](113) [HTML](0) [PDF 482.63 K](237)
    Abstract:
    9  Emphasis on the early diagnosis and precise intervention of hyperammonemia
    Zhang Yao,Yang Yanling
    2022, 47(3):285-289.
    [Abstract](587) [HTML](0) [PDF 747.49 K](240)
    Abstract:
    Hyperammonemia is a severe metabolic disorder. If left untreated,it could lead to various degrees of damage of brain and liver,resulting in unconsciousness,psychomotor disturbance,brain edema,disability and high mortality. There may be several genetic and non-genetic diseases to cause hyperammonemia. The etiology of hyperammonemia is complex,such as urea cycle disorders,organic acidemias,acute or chronic inflammatory liver diseases and drug-induced liver damage. Ten genetic disorders are known as the causes of primary urea cycle defect,and hyperammonemia is the main manifestation. The patients of organic acid metabolic disorders,such as methylmalonic acidemia,propionic acidemia and isovaleriuria,are often complicated with metabolic acidosis and hyperammonemia at the acute stage. The patients of mitochondrial fatty acid metabolic disorders and hyperinsulinemic hyperammonemia syndrome are usually presented with hypoglycemia and hyperammonemia in the acute phase. Early detection of hyperammonemia,etiological diag-nosis and precise treatment are keys to improve the prognosis and the quality of life of patients and their families.
    10  Advances of RASopathies in short stature
    Li Mengting,Shen Yiping
    2022, 47(3):290-295.
    [Abstract](148) [HTML](0) [PDF 7.75 M](271)
    Abstract:
    RASopathies are a group of disorders characterized by mutations in genes that encode components of the Ras/mitogen activated protein kinase(MAPK) pathway. Ras/MAPK pathway plays a critical role in cell differentiation,proliferation and survival. Therefore,RASopathies have overlapping phenotypic features which may lead to difficult diagnosis. As a common phenotype,short stature affects most RASopathies patients. Due to complex possible mechanisms for short stature,growth hormone(GH) therapy efficacy remains to be elucidated and further research. In this review,we summarize short stature that associated with RASopathies and highlight the GH therapy in reported affected individuals with RASopathies.
    11  Advances in the diagnosis and treatment of carbonic anhydrase VA deficiency
    Wu Jing,Chen Zhehui,Song Jinqing,Jin Ying,Li Mengqiu,Zhang Yao,Zhang Jing,Yang Yanling
    2022, 47(3):296-299.
    [Abstract](131) [HTML](0) [PDF 651.33 K](203)
    Abstract:
    Mitochondrial carbonic anhydrase VA deficiency is a rare autosomal recessive disease that can lead to hyperammoniacal encephalopathy. The reported cases had the onset of hyperammoniacal encephalopathy from newborn period(the first day of life) to early childhood(up to the age of 4 years). It would interfere with the activities of a variety of mitochondrial enzymes and result in gluconeogenesis and aerobic oxidation disorders,branched chain amino acids catabolism and urea cycle disorders. Human mitochondrial carbonic anhydrase VA gene CA5A was originally cloned and located in 16q24.3 region in 1993,but the first case of disease caused by carbonic anhydrase VA deficiency was reported in 2014 by van Karnebeek et al. So far,only less than 30 cases have been reported world-wide,among which mostly described patients came from the South Asia,and the global incidence is unknown.
    12  Clinical phenotype and genotype characteristics of 17 cases of Noonan syndrome
    Zhang Wen,Lin Yunting,Li Duan,Li Xiuzhen,Tao Chunyan,Mei Huifen,Cheng Jing,Jiang Minyan,Liu Li
    2022, 47(3):300-305.
    [Abstract](154) [HTML](0) [PDF 1.26 M](224)
    Abstract:
    Objective:To analyze and summarize the clinical characteristics and genetic analysis results of 17 children with Noonan syndrome(NS),and to improve the diagnosis and expand the knowledge of the disease. Methods:The clinical data of 17 patients with NS who were diagnosed in Guangzhou Women and Children’s Medical Center from October 2015 to February 2021 were retrospec-tively analyzed. Gene analysis was performed using whole exome sequencing and Sanger sequencing. Results:Seventeen children including 11 boys and 6 girls were diagnosed with Noonan syndrome in our hospital and the median age was 4 years(5 months to 11 years and 10 months). All cases had typical facial features of Noonan syndrome,accompanied by different degrees of psychomotor retardation,with 16 cases of short stature(SDS<-2),3 cases of cryptorchidism,3 cases of pectus carinatum,3 cases of pectus excavatum and 2 cases of curly hair. Abnormal cardiac structure was founded in 8 cases,including 3 cases of pulmonary valve stenosis with atrial septal defect,2 case of atrial septal defect,1 case of pulmonary valve stenosis,1 case of patent ductus arteriosus with mitral valve prolapse and 1 case of ventricular hypertrophy. Among 17 cases,we identified 17 different mutations:5 missense mutations of PTPN11 gene,4 missense mutations of BRAF gene,3 missense mutations of KRAS gene,2 missense mutations of SHOC2 gene,1 missense mutation of RAF1 gene,1 small deletion of CBL gene and 1 missense mutation of SOS1 gene. Four novel pathogenic mutations were detected,including PTPN11 gene mutation p.R4G and p.H426R,RAF1 gene mutation p.V263G and CBL gene mutation p.R631Dfs*17,and the remaining 13 mutations were known pathogenic mutations. One was maternal,and 16 were de novo mutations. Three patients were treated with recombinant human growth hormone,and their height was significantly improved,without adverse events during the regular follow-up. One case had metoprolol because of cardiac hypertrophy. Conclusion:NS presents divergent phenotypes and the utility of whole exome sequencing in the precise diagnosis is emphasized. Early diagnosis and treatment helps to improve the prognosis of NS.
    13  Clinical characteristics and genetic analysis of 7 children with pseudoachondroplasia
    Xu Lei,Yang Yu,Yang Li,Xie Liling,Zhang Dongguang,Huang Hui,Zou Haiying
    2022, 47(3):306-312.
    [Abstract](144) [HTML](0) [PDF 7.93 M](276)
    Abstract:
    Objective:To analyze the clinical characteristics of children with pseudoachondroplasia(PSACH)and gene mutation sites of cartilage oligomer matrix protein(COMP). Methods:The clinical characteristics,laboratory examination,imaging examination,gene report results and family history were collected from 7 patients diagnosed with PSACH in Jiangxi Provincial Children’s Hospital(including 4 boys and 3 girls,aged from 2 to 9 years old). With “PSACH”,“PSEUDOACHONDROPLASIA”,“COMP gene” and “COMP” as keywords,the literature of PSACH was retrieved respectively from the PubMed,Online Mendelian Inheritance in Man(OMIM),China National Knowledge Infrastructure(CNKI) and WANFANG databases,and it was analyzed that whether the gene mutation sites of these 7 children were consistent with those reported abroad and whether there were newly developed mutations and extended gene mutation spectrum. Results:The stature of the subjects were all 3 standard deviations lower than those of children of the same age and gender,and their appearance and body shape were normal in infancy. At about 2 years old,they showed slowed growth rate and skeletal abnormalities,and walked like a duck. There were no obvious abnormalities in intelligence,face,vision and hear-ing. The X-ray film performance of the subjects were similar,including flat spinal vertebral body,prominent frontal ligule,normal intervertebral disc,shallow acetabulum development,coarse hip,broadened distal femur and stem epiphyseal end of proximal tibia and fibula,irregular shape,rough feeling,stubby long bones,blood calcium and blood phosphorus,and normal PTH metabolic indexes. Besides,all exons tests found COMP gene locus mutation,among which,2 were new mutations,and most of them were missense mutations(6/7). The 7 patients in this study were all located in exon 8-14,including 5 in exon 13 and all located in T36~7. Conclusion:Children around 2 years old who have significant slowed growth rate,short deformity,asymmetrical limb and cartilage epiphyseal dysplasia,oblate spinal vertebral,and duck-like walking gait should be suspected with PSACH,and COMP gene check should be conducted to help diagnose. In addition,other COMP test is also a good diagnostic method. When it is difficult to diagnose PSACH through the clinical phenotype,it can be identified by exon region and domain where COMP mutation is located. PASCH is an autosomal dominant inheritance with high genetic probability. Therefore,early diagnosis and early treatment of complications are of great help to improve the quality of life and healthy birth and breeding.
    14  Clinical, biochemical,imaging and genetic characteristics of Menkes disease
    Qiao Pingyun,Zheng Xuan,Chen Wan,Xu Kaili,Yin Xiaojing,Nie Lei,Wang Yali,Lü Nan,Chen Guohong,Yang Yanling
    2022, 47(3):313-318.
    [Abstract](182) [HTML](0) [PDF 2.67 M](257)
    Abstract:
    Objective:To investigate the clinical phenotypes,imaging and genetic features of Menkes disease(MD). Methods:Seven children were analyzed who were diagnosed as MD by serum ceruloplasmin determination,brain magnetic resonance imaging and gene detection in Children’s Hospital Affiliated to Zhengzhou University from 2016 to 2021. Results:All the 7 cases had the onset to MD at the age of 2 to 6 months,with backward intelligence and movement,sparse and curly hair,white skin,low muscle tone,abnormal hair and face;5 cases were accompanied by convulsions;2 children had feeding difficulties,weakness,fracture and rickets. Serum ceruloplasmin,erythrocyte and hemoglobin decreased and blood lactate increased in 7 children. MRA of the head showed specific tortuous blood vessels and sparse branches. MRI of the head showed subdural effusion,backward development of myelin sheath in white matter,intracranial hemorrhage,abnormal signals in basal ganglia and corpus callosum,brain atrophy,cortical softening and necrosis,hemosiderin deposition,etc. Two children had spontaneous fracture,and one child had obvious rickets-like bone disease. ATP7A gene mutations were detected in 7 children,of which 5 were unreported new mutations. Conclusion:Among the 7 children in this study diagnosed as MD by clinical,biochemical,imaging and genetic examination,5 new mutations of ATP7A gene were found,which guided the family genetic counseling and prenatal diagnosis,and enriched the mutation spectrum of pathogenic genes of MD. A case of MD complicated with fracture was reported for the first time in China.
    15  Study on phenotype and genotype of short stature based on second-generation sequencing technology
    Wu Rui,Shi Yu,Huang Daochao,Li Shuxiang,Wu Liting,Zhou Quansheng,Gui Junfeng,Cai Yiqing,Song Cui
    2022, 47(3):319-324.
    [Abstract](158) [HTML](0) [PDF 816.68 K](282)
    Abstract:
    Objective:To summarize the genotypic and phenotypic characteristics of patients with short stature based on the clinic feature and second-generation sequencing technology. Methods:Patients met the criteria of short stature were included in study who visited the Department of Endocrinology and Genetic Metabolism,Children’s Hospital of Chongqing Medical University from May 2015 to May 2020. The phenotypes of the patients were collected and the genotypes of patients were analyzed by second-generation sequencing technology. Results:The study included 175 patients,of which 81 were found pathogenic or likely pathogenic gene mutations,with a detection rate of 46.29%;there were 46 single gene mutations,10 copy number variations,2 gene imprinting abnor-malities and 1 chromosome abnormality;29 unreported mutation sites were found. The gene diagnosis rate of patients with syndromic short stature was higher in this cohort,and the patients with short stature,accompanied with bone X-ray abnormality,bone deformity,special face,sexual development disorder and stunting were more likely to have genetic etiology. Conclusion:The second-generation sequencing technology is helpful to clarify the genetic etiology of patients with short stature and expand clinicians’ understanding of genotype and phenotype of patients with short stature at molecular level.
    16  A case report of malonyl-CoA decarboxylase deficiency
    Wu Huirong,Xie Rongrong,Chen Xiuli,Wang Xiaoyan,Chen Linqi
    2022, 47(3):325-327.
    [Abstract](193) [HTML](0) [PDF 744.81 K](264)
    Abstract:
    17  Witteveen-Kolk syndrome and literatures review
    Leng Jie,Cheng Xinran,Wang Liuxu Zhang Jing
    2022, 47(3):328-331.
    [Abstract](195) [HTML](0) [PDF 7.09 M](283)
    Abstract:
    18  A case report of congenital hyperinsulinemia with Fanconi syndrome caused by HNF4α gene mutation
    Liu Zhufeng,Wang Wenhong,Wang Xin
    2022, 47(3):332-335.
    [Abstract](116) [HTML](0) [PDF 1.06 M](270)
    Abstract:
    19  A novel mutation of the G6PC gene identified in a child with glycogen storage disease type Ⅰa
    Zhang Guiping,Li Lei,Shu Xiaomei
    2022, 47(3):336-340.
    [Abstract](96) [HTML](0) [PDF 3.19 M](256)
    Abstract:
    20  Two cases of severe combined immunodeficiency caused by IL-7R gene defect and literature review
    Zhang Ting,Li Xin,Li Ming
    2022, 47(3):341-343.
    [Abstract](98) [HTML](0) [PDF 481.39 K](199)
    Abstract:
    21  Autoimmune polyglandular syndromes caused by a novel gain-of-function mutation in STAT3:a case report and literature review
    Chen Dandan,Zhou Qiaoli,Gu Wei
    2022, 47(3):344-347.
    [Abstract](138) [HTML](0) [PDF 858.09 K](222)
    Abstract:
    22  A case report of congenital malabsorption diarrhea caused by NEUROG3
    Wen Jing,Yang Ying,Liu Yu,Gao Aimin,Lu Yan,Cai Qin
    2022, 47(3):348-350.
    [Abstract](96) [HTML](0) [PDF 945.36 K](207)
    Abstract:
    23  A case report of hereditary sensory and autonomic neuropathy with retinopathy caused by FLVCR1 gene mutation
    Peng Yanyan,Feng Bin,Jiang Xianhe,Li Tianxin,Lu Xiangpeng,Wang Yizhen,Zheng Hong,Ma Bingxiang
    2022, 47(3):351-354.
    [Abstract](98) [HTML](0) [PDF 1.62 M](235)
    Abstract:
    24  A case report of MRD57 caused by TLK2 gene mutation
    Ma Chen Jiang Lihong Zheng Jiaqi Niu Lele Liu Geli
    2022, 47(3):355-357.
    [Abstract](100) [HTML](0) [PDF 896.06 K](228)
    Abstract:
    25  Genotype and phenotype analysis of a case of congenital anomalies of kidney and urinary tract syndrome with or without hearing loss,abnormal ears or developmental delay caused by PBX1 mutation
    Wu Liting,Shi Yu,Huang Daochao,Wu Rui,Li Shuxiang,Zhou Quansheng,Gui Junfeng,Cai Yiqing,Song Cui
    2022, 47(3):358-362.
    [Abstract](129) [HTML](0) [PDF 7.67 M](310)
    Abstract: